TY - JOUR A1 - Himmelsbach, Vera A1 - Knabe, Mate A1 - Ferstl, Philip A1 - Peiffer, Kai-Henrik A1 - Stratmann, Jan Alexander A1 - Wichelhaus, Thomas Alexander A1 - Hogardt, Michael A1 - Kempf, Volkhard A. J. A1 - Zeuzem, Stefan A1 - Waidmann, Oliver A1 - Finkelmeier, Fabian A1 - Ballo, Olivier Karl Friedrich T1 - Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma T2 - Journal of cancer research and clinical oncology N2 - Introduction: MDRO-colonization has been shown to impair survival in patients with hematological malignancies and solid tumors as well as in patients with liver disease. Despite the increasing spread of multidrug-resistant organisms (MDRO), its impact on patients with hepatocellular carcinoma (HCC) has not been studied. We conducted this retrospective study to analyze the impact of MDRO-colonization on overall prognosis in HCC patients. Materials and methods: All patients with confirmed HCC diagnosed between January 2008 and December 2017 at the University Hospital Frankfurt were included in this study. HCC patients with a positive MDRO screening before or within the first 90 days after diagnosis of HCC were defined as colonized HCC patients, HCC patients with a negative MDRO screening were defined as noncolonized HCC patients. Results: 59 (6%) colonized and 895 (94%) noncolonized HCC patients were included. Enterobacterales with extended-spectrum β-lactamase-like phenotype with or without resistance to fluoroquinolones (ESBL/ ± FQ) were the most frequently found MDRO with 59%, followed by vancomycin-resistant Enterococcus faecium with 37%. Colonized HCC patients had more severe cirrhosis and more advanced HCC stage compared to noncolonized HCC patients. Colonized HCC patients showed an impaired survival with a median OS of 189 days (6.3 months) compared to a median OS of 1001 days (33.4 months) in noncolonized HCC patients. MDRO-colonization was identified as an independent risk factor associated with survival in multivariate analysis. Conclusion: MDRO-colonization is an independent risk factor for survival in patients with HCC highlighting the importance of regular MDRO screening, isolation measures as well as interdisciplinary antibiotic steward-ship programs to guide responsible use of antibiotic agents. KW - Hepatocellular carcinoma KW - Multidrug-resistant organisms KW - Infection KW - Antibiotic steward-ship KW - Antibiotics KW - ESBL KW - VRE KW - Survival KW - Liver cancer Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/69759 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-697591 SN - 1432-1335 N1 - Open Access funding enabled and organized by Projekt DEAL. VL - 148 IS - 6 SP - 1465 EP - 1472 PB - Springer CY - Berlin ; Heidelberg ER -